First OC Dermatology
Hospital
Location:
Irvine, CA,
United States (USA) (US)
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study. (2026)
Silverberg JI, Rosmarin D, Bieber T, Chovatiya R, Gooderham M, Gkalpakiotis S, Reich A, et al.
Journal article